181 related articles for article (PubMed ID: 22101351)
1. Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia.
Biancotto A; Dagur PK; Fuchs JC; Wiestner A; Bagwell CB; McCoy JP
Mod Pathol; 2012 Feb; 25(2):246-59. PubMed ID: 22101351
[TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells.
Piper KP; Karanth M; McLarnon A; Kalk E; Khan N; Murray J; Pratt G; Moss PA
Clin Exp Immunol; 2011 Nov; 166(2):154-63. PubMed ID: 21985361
[TBL] [Abstract][Full Text] [Related]
3. The role of regulatory T cell (Treg) subsets in gestational diabetes mellitus.
Schober L; Radnai D; Spratte J; Kisielewicz A; Schmitt E; Mahnke K; Fluhr H; Uhlmann L; Sohn C; Steinborn A
Clin Exp Immunol; 2014 Jul; 177(1):76-85. PubMed ID: 24547967
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children.
Freguja R; Gianesin K; Mosconi I; Zanchetta M; Carmona F; Rampon O; Giaquinto C; De Rossi A
Clin Exp Immunol; 2011 Jun; 164(3):373-80. PubMed ID: 21438872
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs.
Steinborn A; Schmitt E; Kisielewicz A; Rechenberg S; Seissler N; Mahnke K; Schaier M; Zeier M; Sohn C
Clin Exp Immunol; 2012 Jan; 167(1):84-98. PubMed ID: 22132888
[TBL] [Abstract][Full Text] [Related]
6. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
[TBL] [Abstract][Full Text] [Related]
7. Reduced circulating CD4+CD25+ cell populations in haemorrhagic fever with renal syndrome.
Zhu LY; Chi LJ; Wang X; Zhou H
Clin Exp Immunol; 2009 Apr; 156(1):88-96. PubMed ID: 19210520
[TBL] [Abstract][Full Text] [Related]
8. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
[TBL] [Abstract][Full Text] [Related]
9. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
[TBL] [Abstract][Full Text] [Related]
10. T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
Palma M; Gentilcore G; Heimersson K; Mozaffari F; Näsman-Glaser B; Young E; Rosenquist R; Hansson L; Österborg A; Mellstedt H
Haematologica; 2017 Mar; 102(3):562-572. PubMed ID: 27927767
[TBL] [Abstract][Full Text] [Related]
11. Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis.
Chiacchio T; Casetti R; Butera O; Vanini V; Carrara S; Girardi E; Di Mitri D; Battistini L; Martini F; Borsellino G; Goletti D
Clin Exp Immunol; 2009 Jun; 156(3):463-70. PubMed ID: 19438599
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.
Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939
[TBL] [Abstract][Full Text] [Related]
13. Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T-cells in chronic lymphocytic leukemia.
Rissiek A; Schulze C; Bacher U; Schieferdecker A; Thiele B; Jacholkowski A; Flammiger A; Horn C; Haag F; Tiegs G; Zirlik K; Trepel M; Tolosa E; Binder M
Int J Cancer; 2014 Nov; 135(10):2370-9. PubMed ID: 24723150
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia.
Gowda A; Ramanunni A; Cheney C; Rozewski D; Kindsvogel W; Lehman A; Jarjoura D; Caligiuri M; Byrd JC; Muthusamy N
MAbs; 2010; 2(1):35-41. PubMed ID: 20081380
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric immunophenotyping of regulatory T cells in chronic lymphocytic leukemia: comparative assessment of various markers and use of novel antibody panel with CD127 as alternative to transcription factor FoxP3.
Dasgupta A; Mahapatra M; Saxena R
Leuk Lymphoma; 2013 Apr; 54(4):778-89. PubMed ID: 22989355
[TBL] [Abstract][Full Text] [Related]
16. Transient regulatory T-cells: a state attained by all activated human T-cells.
Pillai V; Ortega SB; Wang CK; Karandikar NJ
Clin Immunol; 2007 Apr; 123(1):18-29. PubMed ID: 17185041
[TBL] [Abstract][Full Text] [Related]
17. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
[TBL] [Abstract][Full Text] [Related]
18. CD4⁺ CD45RA⁻ FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes.
Haseda F; Imagawa A; Murase-Mishiba Y; Terasaki J; Hanafusa T
Clin Exp Immunol; 2013 Aug; 173(2):207-16. PubMed ID: 23607886
[TBL] [Abstract][Full Text] [Related]
19. Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.
Beyer M; Classen S; Endl E; Kochanek M; Weihrauch MR; Debey-Pascher S; Knolle PA; Schultze JL
Clin Dev Immunol; 2011; 2011():734036. PubMed ID: 21904560
[TBL] [Abstract][Full Text] [Related]
20. Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function.
Burton CT; Westrop SJ; Eccles-James I; Boasso A; Nelson MR; Bower M; Imami N
Clin Exp Immunol; 2011 Nov; 166(2):191-200. PubMed ID: 21985365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
